decisionhealth Newsletters, Part B News - 2002 Issue 11 (November)
Antigen prep for allergen immunotherapy undervalued, OIG finds
Subscribe or sign in to view the full article.
Article Overview
This article covers an OIG report examining Medicare payment valuation for allergen immunotherapy preparation, including CMS’s response and planned review of practice expense inputs. It also discusses how a CPT Editorial Panel definition change affected utilization and why specialty-based practice patterns were noted by the report. The piece is relevant to coders, allergists, and reimbursement professionals following Medicare physician payment policy and CPT-based service definitions.
Why This Topic Matters
It matters because changes to practice expense inputs and service definitions can affect reimbursement policy, billing interpretation, and how allergy immunotherapy preparation is reported and valued in the Medicare program.
What You Will Learn
- How an OIG review evaluated practice expense valuation for allergen immunotherapy preparation
- How CMS responded to the report and its planned review of practice expense inputs
- Why a CPT Editorial Panel definition change was noted in the discussion of utilization
- What general specialty-level practice pattern differences were highlighted
Who Should Read This
- Medical coders
- Allergists
- Physician offices
- Revenue cycle professionals
- Compliance staff
- Healthcare reimbursement analysts
Codes Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com